New Californian startup selling ‘young blood’ to the rich

A few months back, word on the grapevine was that there was a start-up selling young adult’s blood to the rich as to restore and reverse some of the symptoms of aging.

Now, as it turns out, a company named ‘Ambrosia LLC’ is charging their clients $8000 per transfusion promising not immortality but the very best thing, reversal of symptoms of aging.

Ambrosia, is a California based company, founded by Jesse Karmazin who studies blood and its constituent parts offering treatments that promise to reverse aging by the means of transfusions, according to Mashable.

Peter Thiel who owned another Californian tech-company, Palantir Technologies told foreign media, “Life-extension science is a popular obsession in Silicon Valley”; needless it’s not to come as a surprise if we see more startups like Ambrosia gaining traction in the time to come.

CNBC reported that Karmazin has accumulated upwards of 80 customers signed up to receive plasma transfusions for their ‘bargain’ price of $8,000. Albeit, the plasma is usually taken from teenagers, with a donor-age cap of 25 at Ambrosia; the customers however are only to be over the age of 35, but Karmazin confirmed most of them are near retirement age.

According to reports by BusinessInsider, Jesse Karmazin further elucidated on the procedure stating, ‘within a month, most participants – see improvements – from the one time infusion of a two-liter bagful of plasma, which is blood with the blood cells removed.”

The 32-year-old Princeton graduate, Karmazin further concluded that he was inspired by the process of ‘Parabiosis’ and studies done on mice in labs that researchers had been working on, where old mice were injected with the blood of young mice reversing most if not all symptoms of aging. Scientists further claim this could very well pave the way for treating mental illnesses like alzheimer's, Parkinson’s, dementia and other neuro-degenerative ailments curing them altogether.